Medicamen Organics Limited (NSE:MEDIORG)
India flag India · Delayed Price · Currency is INR
30.20
+2.10 (7.47%)
Apr 16, 2026, 2:30 PM IST

Medicamen Organics Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
353254----
Enterprise Value
485362----
Last Close Price
30.2021.70----
PE Ratio
7.866.27----
PS Ratio
0.900.67----
PB Ratio
1.070.83----
P/TBV Ratio
1.090.84----
EV/Sales Ratio
1.230.95----
EV/EBITDA Ratio
7.075.64----
EV/EBIT Ratio
7.486.21----
Debt / Equity Ratio
0.480.410.831.311.281.30
Debt / EBITDA Ratio
2.281.922.676.278.555.99
Net Debt / Equity Ratio
0.390.270.791.251.221.18
Net Debt / EBITDA Ratio
1.861.282.565.998.195.42
Net Debt / FCF Ratio
-4.91-1.18-3.02-12.90-16.94-6.99
Asset Turnover
0.720.780.710.740.790.98
Inventory Turnover
3.313.642.572.914.244.51
Quick Ratio
1.181.100.800.520.380.51
Current Ratio
1.771.671.260.950.880.90
Return on Equity (ROE)
15.17%17.70%21.65%11.41%1.32%3.37%
Return on Assets (ROA)
7.36%7.47%7.07%2.44%1.22%1.99%
Return on Invested Capital (ROIC)
10.83%13.16%9.98%4.39%1.21%3.31%
Return on Capital Employed (ROCE)
18.60%18.20%23.90%11.00%5.20%9.10%
Earnings Yield
12.95%15.94%----
FCF Yield
-7.35%-27.53%----
Buyback Yield / Dilution
-28.87%-46.18%-26.05%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.